INNOVIVE Pharmaceuticals Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $19.8M

INNOVIVE Pharmaceuticals General Information

Description

Developer of novel therapeutics addressing significant unmet medical needs in the fields of oncology and hematology. The company is engaged in the development of compounds for the treatment of cancer.

Contact Information

Website
www.innovivepharma.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 787 Seventh Avenue
  • 48th Floor
  • New York, NY 10019
  • United States
+1 (212)
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Acquirer
LadRx
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 787 Seventh Avenue
  • 48th Floor
  • New York, NY 10019
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

INNOVIVE Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 22-Sep-2008 $19.8M Completed Generating Revenue
5. PIPE 25-Apr-2007 Completed Generating Revenue
4. IPO 13-Oct-2006 Completed Generating Revenue
3. Early Stage VC (Series A) 29-Jun-2006 Completed Product Development
2. Early Stage VC 29-Jun-2005 $2.25M $2.25M Completed Product Development
1. Early Stage VC Completed Product Development
To view INNOVIVE Pharmaceuticals’s complete valuation and funding history, request access »

INNOVIVE Pharmaceuticals Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cranshire Capital Advisors PE/Buyout Minority
Global Investment Holdings Venture Capital Minority
Henderson Equity Partners Fund of Funds Minority
Paramount BioSciences Venture Capital Minority
Pearl Capital Partners Growth/Expansion Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

INNOVIVE Pharmaceuticals FAQs

  • When was INNOVIVE Pharmaceuticals founded?

    INNOVIVE Pharmaceuticals was founded in 2004.

  • Where is INNOVIVE Pharmaceuticals headquartered?

    INNOVIVE Pharmaceuticals is headquartered in New York, NY.

  • What industry is INNOVIVE Pharmaceuticals in?

    INNOVIVE Pharmaceuticals’s primary industry is Drug Delivery.

  • Is INNOVIVE Pharmaceuticals a private or public company?

    INNOVIVE Pharmaceuticals is a Private company.

  • What is the current valuation of INNOVIVE Pharmaceuticals?

    The current valuation of INNOVIVE Pharmaceuticals is .

  • What is INNOVIVE Pharmaceuticals’s current revenue?

    The current revenue for INNOVIVE Pharmaceuticals is .

  • How much funding has INNOVIVE Pharmaceuticals raised over time?

    INNOVIVE Pharmaceuticals has raised $30.8M.

  • Who are INNOVIVE Pharmaceuticals’s investors?

    Cranshire Capital Advisors, Global Investment Holdings, Henderson Equity Partners, Paramount BioSciences, and Pearl Capital Partners are 5 of 7 investors who have invested in INNOVIVE Pharmaceuticals.

  • When was INNOVIVE Pharmaceuticals acquired?

    INNOVIVE Pharmaceuticals was acquired on 22-Sep-2008.

  • Who acquired INNOVIVE Pharmaceuticals?

    INNOVIVE Pharmaceuticals was acquired by LadRx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process